Conformational transformation and selection of synthetic prion strains

Sina Ghaemmaghami1, Joel C Watts, Hoang-Oanh Nguyen

  • 1Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA 94143, USA.

Insights

Prion protein strains can transform and adapt within a host. This study reveals that conformational changes and competitive selection drive prion evolution, impacting neurological disease.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Prion diseases are caused by misfolded prion proteins forming distinct strains.
  • Prion strains can mutate or transform despite lacking genetic material.

Purpose of the Study:

  • To investigate the mechanism of prion strain transformation.
  • To analyze the physicochemical evolution of a mouse synthetic prion (MoSP) strain.

Main Methods:

  • Studied the physicochemical evolution of MoSP1 after repeated passage in mice and cell cultures.
  • Analyzed changes in incubation times, conformational stability, and protease-resistant core molecular mass.
  • Investigated strain competition in cell cultures and the influence of culture media composition.

Main Results:

  • MoSP1 evolved shorter incubation times and lower conformational stability.
  • A structural transformation occurred, shifting the protease-resistant core mass from 19 kDa to 21 kDa.
  • The MoSP1(1) strain preferentially proliferated over MoSP1(2) when mixed, leading to the disappearance of MoSP1(2).
  • Culture media composition and polyamidoamines influenced the transformation rate.

Conclusions:

  • Prions exist as conformationally diverse populations of strains capable of high-fidelity replication.
  • Conformational conversion followed by competitive selection provides a mechanism for prion adaptation to the host environment.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Transformation01:26

Transformation

Microbial communities are dynamic environments where cell lysis releases free DNA into the surroundings. Other cells can take up this extracellular DNA through a process known as transformation.When a cell incorporates this foreign DNA into its genome, resulting in genetic modification, the process is known as transformation. Cells capable of this process are termed competent. Competence can be natural, as observed in certain bacteria and archaea, or artificially induced in the...